The New York Obesity Nutrition Research Center Pilot & Feasibility (PF) program provides support for basic and clinical research projects related to obesity, its etiology and complications. Since its inception 35 years ago, this program has been used successfully to 1. attract and underwrite young investigators who wish to undertake a career in obesity; 2. encourage established investigators proposing work related to obesity, outside of their usual areas of research; 3. promulgate high-risk projects that expand the NYONRC's reach into new areas of bioscience deemed likely to have relevance to aspects of our mission; 4. promote collaborative research projects among Center members and the Cores. Of the 90 prior recipients, 66 are still in obesity/nutrition academic research, four are in teaching, and seven are in industry. In the past 10 years, 21 of the recipients have been early investigators and 2 have been established investigators. To date, these 23 P/F grantees have acquired 25 grants, funded by NIH (n=16), and private foundations (n=9). The total annual direct costs for these 25 grants are nearly $3.4 M. We consider this program to be among the most important elements of the Center, and have take steps to increase the resources available to it. For this renewal we have, therefore, increased the requested budget for this program to $100k per annum of Center funds, and obtained commitments from the Deans of Columbia and Einstein for an additional $125k per annum. This $225k of annual funding will enable us to have 4-5 P&F grants (@ ~$45k per annum) active in any year. In addition, our closely integrated programs of the Berrie Center ? Berrie Frontiers Fellows and Scholars ? brings an additional $430k in per annum funding for programs focused on early stage fellows and faculty in the area of obesity, diabetes and allied metabolic disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK026687-40
Application #
9901513
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
40
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Carli, Jayne F Martin; LeDuc, Charles A; Zhang, Yiying et al. (2018) The role of Rpgrip1l, a component of the primary cilium, in adipocyte development and function. FASEB J 32:3946-3956
Gallagher, Dympna; Rosenn, Barak; Toro-Ramos, Tatiana et al. (2018) Greater Neonatal Fat-Free Mass and Similar Fat Mass Following a Randomized Trial to Control Excess Gestational Weight Gain. Obesity (Silver Spring) 26:578-587
Rosenbaum, Michael; Goldsmith, Rochelle L; Haddad, Fadia et al. (2018) Triiodothyronine and leptin repletion in humans similarly reverse weight-loss induced changes in skeletal muscle. Am J Physiol Endocrinol Metab :
Gallagher, Dympna; Rizkalla, Bridgette (2018) The 11th International Symposium on In Vivo Body Composition Studies. Eur J Clin Nutr :
Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:
Martin Carli, Jayne F; LeDuc, Charles A; Zhang, Yiying et al. (2018) FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications. J Lipid Res 59:1446-1460
Blumenfeld, Nicole R; Kang, Hwan June; Fenzl, Anna et al. (2018) A direct tissue-grafting approach to increasing endogenous brown fat. Sci Rep 8:7957
Ravussin, Yann; Edwin, Ethan; Gallop, Molly et al. (2018) Evidence for a Non-leptin System that Defends against Weight Gain in Overfeeding. Cell Metab 28:289-299.e5
Shechter, Ari; Kim, Elijah Wookhyun; St-Onge, Marie-Pierre et al. (2018) Blocking nocturnal blue light for insomnia: A randomized controlled trial. J Psychiatr Res 96:196-202
Sui, Lina; Danzl, Nichole; Campbell, Sean R et al. (2018) ?-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells. Diabetes 67:26-35

Showing the most recent 10 out of 809 publications